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Objective:Acutewoundfailureisacommoncomplicationfollowingsurgicalprocedures
and trauma. Laparotomy wound failure leads to abdominal dehiscence and incisional
hernia formation. Delayed recovery of wound-breaking strength is one mechanism for
laparotomywoundfailure.Earlyfascialwoundsarerelativelyacellular,andthereisade-
lay in the appearance of acute wound growth factors and cytokines. The objective of this
study was to accelerate and improve laparotomy wound healing using amnion-derived
multipotent cells (AMPs). AMPs’ nonimmunogenic phenotype and relative abundance
support its role as a cell therapy. Methods: AMPs were injected into the load-bearing
layerofratabdominalwallspriortolaparotomy,andcellviabilitywasconfirmed.Wound
mechanical properties were measured over 28 days. The incidence and severity of la-
parotomy wound failure was measured in an incisional hernia model. Results: AMP
cells were viable in laparotomy wounds for at least 28 days and did not migrate to other
tissues. Laparotomy wound-breaking strength was increased by postoperative day 7 fol-
lowing AMP therapy. AMP therapy reduced the incidence of hernia formation and the
size of hernia defects. Histology suggested stimulated wound fibroplasia and angiogen-
esis. Conclusions: AMP cell therapy reduces the incidence of laparotomy wound failure
by accelerating the recovery of wound-breaking strength. This results in fewer incisional
hernias and smaller hernia defects.
An acute wound is defined as a traumatic loss of normal structure and function to
recentlyuninjuredtissueafteranoxiousinsult.1 Acutewoundhealingisthehighlyregulated
process of cellular, humoral, and molecular events activated at the time of acute injury and
resulting in a time-dependent but predictable and orderly pattern of tissue repair.2 Unlike
chronic wounds, most acute wounds heal. The problem with acute wounds is that they take
a long time to heal, are meanwhile disabling, and most often result in scar.3
Acute wound healing failure occurs when there is an abnormality in the degree or
duration of the sequential components of tissue repair.1 Optimizing the management of
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acute wounds to prevent wound failure has been a major goal of surgical science over the
past100years.Primarystrategieshavereliedmainlyonmechanicalapproachestotheprob-
lem of acute wound healing failure. However, purely mechanical approaches to the problem
of acute wound failure ignore the important role that the biologic response of injured tissue
plays in wound-healing outcomes.1
Most biomechanical failures occur early on the acute wound healing trajectory at a
time when wound strength is essentially zero and patients are recovering and increasing the
loads placed across the abdominal wall.4,5 The goal of most acute wound healing research
is to better define the combined biomechanical mechanism of acute wound healing failure
at the tissue, cellular, and molecular levels. A major focus is fibroblast activation out of
quiescence and cell cycle progression after surgical injury and how this correlates with the
quality of early tissue repair.1 Whether fascial wound failure reflects a defect in fascial
fibroblastrecruitmentandfunctionduringincisionalherniaformationorwhetherabnormal
mechanical signals after fascial wound failure subsequently results in impaired fibroblast
function is not known.1 Another focus to improve acute wound healing and decrease acute
woundfailurehasbeentheuseofcytokinegrowthfactorswhichhasdecreasedtheincidence
of incisional hernias in experimental models.4,6,7
Stemcellsandstemcell-likemultipotentcellshavetheabilitytodifferentiateintomany
different cell types important to wound healing and tissue repair.8–10 They are also known
to produce cytokine growth factors that serve as mediators to the cellular processes of the
wound-healing scheme perhaps in a more “physiologic” way.9–11 Amnion-derived cells dis-
play many favorable characteristics of stem cells, including the ability to differentiate into
various cell types.12,13 They also have been shown to secrete many cytokines and growth
factors.14–16 Amnion-derivedcellshavetheadditionaladvantagesofbeingabundantlyavail-
able, not inhibited by social, ethical, or religious strictures, and have been reported to be
nonimmunogenic.17
The purpose of the studies reported here was to use proprietary amnion-derived mul-
tipotent progenitor cells (AMPs) provided by Stemnion Inc., Pittsburgh, PA, to attempt to
accelerate the gain of surgical incision breaking strength and, in so doing, decrease the
incidence and severity of acute wound failure.
MATERIALS AND METHODS
AMP and GFP-labeled AMP (AMP-GFP)
Proprietary amnion-derived multipotent progenitor cells (AMP) and green fluorescent pro-
tein labeled AMP (AMP-GFP) were provided by Stemnion Inc., Pittsburgh, PA. Amnion
cellswereharvestedfromplacentasdeliveredatthetimeofcaesareansectionandprocessed
by proprietary techniques. The cells were transported frozen and thawed immediately prior
to experimental application.
Animal model
The rat models of laparotomy healing and incisional hernias were previously reported.18,19
Sprague-Dawley rats (Harlan Inc, Indianapolis, IN) weighing 450 to 500 g were acclimated
and housed under standard conditions. Animals were allowed ad libitum intake of standard
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Figure 1. Delivery of NS or AMP suspension in NS into
linea alba. 200 µLN So rAMP NS suspension was in-
jected along 5 cm of the linea alba using a 22G needle
(0.7mm×38mm).Eventissuedistributionwasachieved.
rat chow and water throughout the study. All animal care and operative procedures were
performedinaccordancewiththeUSPublicHealthServiceGuidefortheCareofLaboratory
Animals (NIH Publication No. 86-23, revised 1985) and were approved by the University
Committee on Use and Care of Animals of University of Michigan.
Laparotomy wound healing model
Briefly, a 6 × 3c mv entral full-thickness skin flap is raised through the avascular prefascial
plane, and a 5-cm full-thickness laparotomy incision is made through the linea alba at the
musculo-tendinous layer of the abdominal wall. The laparotomy is repaired with a running,
4-0 polypropylene suture using 0.3 cm suture bites and 0.5 cm progress between stitches.
The suture is tied to itself at the end of the wound. The skin flap is sutured in place with
three 4-0 polypropylene stitches and steel wound clips. After 30 minutes of recovery under
a heat lamp, the rats are returned to fresh individual cages.
Twog roups were studied: (1) a normal saline treated (NS-control-S) abdominal wall
group and (2) a NS washed, human amnion-derived multipotent progenitor cell primed
(AMP-S) abdominal wall group. In the NS control group, the midline of the abdominal
wall (linea alba) was injected for 5 cm with 200 µLo fN S(priming). In the AMP-S group,
200 µLN Scontaining 106 amnion epithelial cells was also injected along the linea alba
for 5 cm. Surgical site priming is achieved with a 22-gauge hypodermic needle (0.7 mm ×
38 mm) into the linea alba (Fig. 1). Soft tissue distribution of NS control or AMP cell
suspension was achieved. After 5 minutes, the laparotomy incision is made and repaired as
described above, closed without laparotomy.
On postoperation day (POD) 7, POD 14 and POD 28, the rats were killed. Iso-
lated abdominal wall muscle and tendon strips and fresh biopsies of the abdominal wall
to laparotomy wound-healing interface were collected for mechanical and histological
testing.
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Laparotomy wound breaking strength and mechanical properties
Mechanical testing was performed on abdominal wall strips collected from the laparotomy
wound healing model as reported.6,19,20 All sutures were removed. Abdominal wall strips
were taken perpendicular to the wound-healing interface. A cutting template was used to
mark the abdominal wall to minimize size variability between specimens. Strips were cut
10 mm in width, 60–80 mm in length. Two strips were collected from each rat, and testing
was performed within 6 hours of necropsy. The fascial tissue strip thickness at the wound
and the length between grips were measured with Digimatic calipers (Mitutoyo American
Corp, Chicago, IL). Stretch loading facilitated mechanical characterization of the wound-
healing interface. Force extension curves were generated for each fascial strip with the use
of an Instron tensiometer (model 5542; Instron Corporation, Canton, MA) equipped with
a 50-newton static load cell set at a crosshead speed of 10 mm per min. The fascial strips
weremountedintotheloadframewiththeuseofpneumaticgrips,preloadedto0.1newtons
with the gauge length measured between the grips that was around 10 mm. The load frame
applied testing loads to the fascial strips until mechanical tissue disruption occurred. The
anatomic location of the break was noted for each specimen. Force and tissue deformation
data were simultaneously recorded and captured on a computer connected to the load frame
viaadigitalinterfacecard.DataanalysiswereperformedwiththeuseoftheMerlinmaterials
testing software package (Instron Corp, Canton, MA) from which breaking strength, the
maximum load force (Fmax)a tmechanical failure (N); tensile strength, the maximum stress
developed in the specimen per unit area, calculated as Fmax/cross-sectional area (N/mm2);
energy at break (mJ), yield strength (N), yield energy (mJ), and stiffness, the slope of the
linear elastic region of the force-extension curve (N/mm) were generated with the Merlin
software package. Failure of the specimen was defined at the yield point, rather than at the
point of ultimate tissue disruption, because the yield point indicates the region where the
tissues are irreversibly deformed (ie, beyond the elastic limit of the tissues).
Incisional hernia model
Failing laparotomy incisions form incisional hernias. Clinically, this manifests as defects in
themuscular-fascial-peritoneallayeroftheabdominalwall.Themostseriousconsequences
of this are the incarceration and obstruction of abdominal viscera, loss of the ability of the
abdominal wall to maintain torso posture, and chronic pain.
The models were made as previously described.18,19 Briefly, a 6 × 3c mv entral full-
thickness skin flap was raised through the avascular prefascial plane, and a 5-cm full-
thickness laparotomy incision was made through the linea alba. Two 5-0 fast absorbing
plain gut stitches were placed on top end and middle point of the laparotomy incision,
respectively. The skin flap is sutured in place with three 4-0 polypropylene stitches and
steel wound clips. Two groups were again used for this experiment: normal saline primed
(NS-H control) abdominal wall group and human amnion-derived multipotent progenitor
cell primed (AMP-H) abdominal wall group. In the NS-H control group, 200 µLN Sw a s
injected along the midline for 5 cm. In the AMP-H group, 200 µLN Scontaining (1–5) ×
106 amnion epithelial cells was injected along the linea alba for 5 cm. On POD 28, the
rats were killed and the musculo-tendinous layer of the abdominal wall was collected and
examined for incisional hernias.
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Figure 2. Measurement of hernia size. Digital
pictures were taken with a ruler as reference for
everysample.SoftwareSpotwasemployedtomea-
sure the calibrated hernia sizes. A digital perime-
ter was drawn along the hernia ring to measure the
hernia size in square centimeters.
Measurement of hernia size
For hernia size measurement, the hernia model rats were killed on POD 28. The skin was
dissectedfreecircumferentiallyand5cm×10cmoftheabdominalwallmusclewasexcised.
The muscle was stretched out and pinned down on a dissecting board at the four corners
with the peritoneal side up. A ruler was set alongside the wound as a reference for every
sample. A standardized digital picture was the taken. Software Spot, Windows: version 4.5
(DiagnosticInstruments,Inc.,SterlingHeights,Michigan,USA)wasemployedtocalculate
the hernia size on digital pictures. Calibration was set up using the rule reference on each
picture. A circle was drawn along the hernia ring to measure the hernia size as square
centimeter (Fig. 2).
Wound and tissue histology
Sagittal fascial laparotomy wound and/or hernia sections were then cut and immediately
fixed in 10% neutral-buffered formalin in preparation for histologic analysis. Specimens
were embedded in paraffin, sectioned, and stained with hematoxylin and eosin or trichrome
byacore research histology service or the Immunoperoxidase Laboratory in the University
of Michigan Comprehensive Cancer Center.
ViablegreenfluorescenceproteinlabeledAMP(GFP-AMP)wasmeasuredinthelinea
alba,spleen,liver,skin,lymphtissue,andtestis.GFP-AMPwereinjectedintothelineaalba
as described above and animals killed on POD 7, 14, and 28. Tissues were collected and
embedded in Optimal Cutting Temperature compound (OCT, Sakura Finetek, Torrance,
California) and snapped in liquid nitrogen immediately. A piece of sagittal fascial wound
from the linea alba was fixed in 105 formalin on ice for 6 hours, dehydrated through graded
sucrose washes for 24 hours, and finally embedded in OCT compound and snapped in
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Figure 3. CulturedGFPlabeledhumanAMP
(AMP-GFP).
liquid nitrogen. Serial cryostat sections were made for fluorescence microscopy to evaluate
distribution or localization of GFP+ cells.
Statistics
Statistic analysis was performed using GraphPad Prism version 4.00 for Windows (Graph-
Pad software, San Diego, CA, www.graphpad.com). t-Test was used to compare the dif-
ference between NS control group and AMP-treated groups. This software was also used
to create the incidence curves of incisional hernia at POD 28 for fractional hernia at any
particular hernia or wound defect size, and compare the curves between NS-H control and
AMP-H groups. Significant level was set at P < 0.05.
RESULTS
Viability of GFP-labeled AMP in experimental wound and hernia models
Successful transplantation requires survival of the transplanted AMP. Reports suggest that
amniotic cells were beneficial for the healing of spinal injury and do not induce immune
rejection reaction.17,21–23 Human amniotic epithelial cells have not been reported to express
ontheirsurfacesHLA-A,B,C,andDRantigens,orbeta2-microglobulin.21 Humanamnion
epithelial cells have been reported to survive up to 7 weeks without inducing acute immune
rejection after allogeneic transplantation of human amniotic epithelial cells. Yeager and
colleagues reported that no residual amniotic epithelium was found in humans at 2 1/2 and
3 1/2 months after human amniotic cell implantation.24
To evaluate the survival of AMP in our models, 2.5 × 106 GFP-labeled AMP were
injected into the linea alba (Fig. 3). Rats were killed on POD 7, 14, and 28. Abdominal
wall tissue around the linea alba injection site was collected. Frozen tissue sections were
made for fluorescence microscopy examination. As shown in Figure 4, high numbers of
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Figure 4. Viability of human AMP-GFP in laparo-
tomywounds.AMP-GFPwereinjectedinratlineaalba
andtissueharvestedover7,14,and28days.Frozentis-
sue sections of abdominal wall collected at these three
time points were examined under a fluorescent micro-
scope. A: POD 7; B: POD 14; C: POD 28. D: Frozen
skin tissue section adjacent to injection site collected
on POD 7.
the cellular elements were found to express GFP in abdominal wall tissue sections of rat
on POD 7, 14, and 28, suggesting AMP survive within this experimental time frame. To
evaluate whether the AMP migrate outside the wound site, tissues of liver, spleen, lymph
nodes, testis, and skin wound adjacent to the laparotomy delivery site were collected and
checked under fluorescent microscope for GFP expression. No GFP expressing cellular
elements were found in the liver, lymph nodes, spleen, and testis (data not shown). As
shown in Figure 4D, GFP positive cellular elements were found in skin specimen adjacent
to the AMP delivery site, suggesting the possibility that AMP could spread locally but not
migrate to distant tissue.
AMP accelerates wound healing in the early postoperative laparotomy incision
According to the published literature, amniotic cells may facilitate the recovery of injury
in the nervous system.17,23,25,26 In this experiment, AMP were delivered to the linea alba to
test AMP’s effect on abdominal wall muscle-tendon wound healing. Tensiometric analysis
was performedonuniformabdominalwallstripswiththelineoftissuedeformationdirectly
perpendicular to the linea alba/incision line. Tensiometric measurements found significant
differences in the mechanical properties between the NS-S and AMP-S groups at the early
phaseofwoundhealing.Allwoundsmechanicallydisruptedatthefascial:fascialinterface.
As shown in Figure 5, wounds treated with 106 AMP/rat developed increased breaking
strength in the early postoperative fascial incision (POD 7). The scar tissue harvested on
POD 7 showed evidence of higher vascularization, more granulation tissue, and organized
fibro-proliferation in the AMP-S group compared with NS-S group (Figs. 5F and G).
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Figure 5. Tensiometric measurements and histology examination on early postoperative inci-
sions. Fascial mechanical breaking characteristics were measured with an Instron tensiometer on
POD 7 (A to F). Values are the mean ± SEM of 6 wound biopsies each from the NS-S control
and the AMP-S groups. t-Test was employed to compare the difference between the 2 groups. ∗:
P < 0.05, ∗∗: P < 0.01. Morphology of fascial incisional wound at POD 7 from NS-S (G) and
AMP-S (H) groups. H&E staining was performed for histology.
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To investigate AMPs’ long-term effect, the period of the experiments was extended to
POD28.Bypostoperative28day,themechanicalwound-breakingcharacteristicsincreased
along with time in both groups. Differences in the recovery of wound-breaking properties
were decreasing on POD 14 and appeared to become less marked with time, consistent with
normal acute wound healing (Fig. 6). There was no statistical difference in wound-breaking
strength or tensile stress on POD 14 and 28 following single dosing of AMP.
AMP reduces laparotomy dehiscence and herniation
Initial experiments showed that AMP augmented wound healing in the early postoperative
fascialincisions.Incisionalherniaofthelaparotomyincisionisaverycommoncomplication
of the human abdominal wall. To test whether AMP improved laparotomy healing and
hernia formation, rat hernia models were treated with AMP cells. (1–5) × 106 AMP in
200 µLN So r2 0 0µLN Sw ere delivered on linea alba over a 5-cm length. A 5-cm fascial
laparotomy incision was made and closed with two fast absorbing suture stitches resulting
inanintentionalincisionalherniamodel.OnPOD28,allratswerekilledandtheabdominal
wall was collected for hernia or wound defect assessment and size measurement. As shown
in Figure 7A, the hernia or wound defect size in AMP-H group was significantly smaller
than those in NS-H group, 0.82 ± 0.16 cm2 versus 2.72 ± 0.56 cm2. Morphology of hernia
ring showed (Figs. 7B and C) that there was more vascularization within the hernia ring
from AMP-H treated rats when compared with the NS-H rat, suggesting accelerated and
improved laparotomy wound repair in the AMP-H group.
Inthebestclinicalstudyofpredictingincisionalhernias,itwasfoundthata12-mmgap
in the laparotomy closure on POD 30 would go on to form a clinically significant incisional
hernia 94% of the time. Conversely, defects less that 12 mm in size on formed important
incisional hernias 3% of the time over 3 years.27 In other words, small laparotomy defects
do not form incisional hernias, but bigger ones do. The majority of AMP-treated animals
developed very small laparotomy defects, if at all. The largest and smallest hernia or defect
sizes were 1.88 and 0 cm2 in AMP-H group versus 6.28 and 0.50 cm2 in NS-H group,
respectively. AMP treatment, therefore, reduces the incidence of laparotomy wound failure
that progresses to an incisional hernia.
DISCUSSION
As stated previously, acute wound failure is a biomechanical failure. When incisions of
the musculo-tendinous layer of the abdominal wall fail, incisional hernias form. The most
seriousconsequencesofthisaretheincarcerationandobstructionofabdominalviscera,loss
of the ability of the abdominal wall to maintain torso posture, and chronic pain. Mechanical
approachestolaparotomyclosure,includingoptimizedsuturelength-to-woundlengthratios,
incisionlocationandorientation,layeredversusmassclosure,andevenmeshherniorrhaphy,
have all failed to eliminate this common surgical complication.28,29
The two most likely mechanisms for acute fascial wound failure leading to incisional
herniaformationhavebeensummarizedasfollows:adefectordelayinrepaircellactivation
and provisional wound matrix crystallization during acute fascial repair leads to herniation,
or herniation resulting from mechanical failure leads to a delay or deficiency in the acute
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Figure 6. Timecourseofmechanicalwoundbreakingpropertyrecovery.Fascialmechanical
breaking characteristics were measured with an Instron tensiometer on 3 time points, POD
7, POD 14, and POD 28. Values are the mean ± SEM of 6 wound biopsies each from the
NS-S control and the AMP-S groups.
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Figure 7. Effect of AMP on hernia healing. Hernia or
wound defect size was measured on POD 28. Values are
the mean ± SEM of 11 hernia biopsies each from the NS-H
control and the AMP-H groups. ∗∗: compared with NS-H,
P < 0.01. Morphology of hernia ring from NS-S (B) and
AMP-S (C) groups. H&E staining was performed on tissue
sections.
woundhealingprocess.1 Itispossiblethatbothmechanismsareactiveinareinforcingcycle
of acute wound failure and herniation.
Theinjuredtissue’smechanicalintegrityisbestmeasuredaswound-breakingstrength.
Wound-breaking strength is the mechanical property of a healing wound and measures the
ability of the early scar to resist distractive forces. Burst abdomens, or acute fascial dehis-
cencewithevisceration,areoneimportantextremeofacutewoundfailure.Burstabdomens
have long been associated with mortalities of almost 50%.28 Less dramatic are incisional
hernias, another example of acute fascial wound healing failure that is a large source of
surgical morbidity. The magnitude of the problem is emphasized by the nearly 50 million
operationsperformedeachyearintheUnitedStates.30 Thisnumberdoesnotincludethean-
nual estimated 50 million traumatic wounds.1 Recovery from these procedures and injuries
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costs 250 million patient-days in lost productivity and billions of dollars in lost or supple-
mental earnings. Despite technical advances, the incidence of fascial dehiscence, incisional
hernia formation, gastrointestinal anastamotic breakdown, pancreatic fistulas, and vascular
pseudoaneurysms has not declined substantially in 75 years of modern surgery.28 Prospec-
tive,well-controlledstudiesfindthatincisionalherniascomprise11%ofallabdominalwall
closures after celiotomy.31,32 In as many as 1 in 3 abdominal wall closures, the fascial layer
of the wound will fail to heal reliably in patients operated upon for aortic aneurysm disease
during periods of hemodynamic instability or in those with gross contamination of the deep
wound space, especially in malnourished patients.28 As a result of such problems, approxi-
mately 200,000 incisional hernia repairs are performed each year in the United States alone
at a financial cost of nearly $ 2.5 billion.30,33 The cost in terms of prolonged recovery times
and patient disability is more difficult to measure.34 With nearly 4 million abdominal and
pelvic operations performed each year in the United States, it is estimated that another
200,000 incisional hernias may be going unrecognized and untreated.6
There are several potential mechanisms by which AMP cells improve the healing of
laparotomy incisions. AMP cells may differentiate into fibroblast-like cells to replace or
augment the fibroblasts made defective by biomechanical stress when the single suture
givesway.Defectshavebeenidentifiedinthekineticpropertiesoffibroblastsculturedfrom
fascial biopsy specimens.35 In these studies, it was observed that fibroblasts cultured from
incisionalherniasweresignificantlydeficientincausingcontractionoffibroblast-populated
collagen lattices. Normally healing fascial fibroblasts caused 80% lattice contraction over
5d a ys, whereas hernia fibroblasts caused only 50% lattice contraction.35 Other groups
observed abnormal collagen isoform production in patients with incisional hernias. It is
possible that a regenerative signal from AMP cells directs accelerated and or normal fascial
fibroblast repair.
AMPcellscouldbemakingthenecessarycytokinecocktailatthepropertimeanddose
to effect a trajectory shift—already proven by our group for individual cytokines such as
TGF-B2, bFGF, and GM-CSF.2,4,35 The immune privilege of amnion-derived cells allows
them to function when applied as an allograft or xenograft.17
Tissue growth factors are an important class of tissue repair signaling peptides up-
regulated during the lag phase of acute wound healing.2 Five to seven days are required,
however, before peak levels of fibroproliferative growth factors like transforming growth
factor beta are reached in acute wounds.36 Acute wound therapy with proliferative growth
factors is known to accelerate the appearance of fibroblasts and collagen into the wound,
thereby shortening the natural lag phase for gain in injured tissue strength.
The preponderance of clinical and basic evidence now supports the concept that very
early laparotomy wound failure is the mechanism of incisional hernia formation. Load-
bearing laparotomy wounds fail at the weakest point on the acute wound healing trajectory,
at the same time that most surgical patients are recovering. Early wound failure lead to
incisional hernia formation more than 94% of the time.27 Well-performed, prospective
series of incisional hernias now report early recurrences, all within 3 years of operation.
It is increasingly accepted that a majority of incisional hernias arise from occult fascial
dehiscences. A new emphasis is, therefore, being placed on improved laparotomy closure
and healing, either through biological manipulation, or with the use of prophylactic, soft-
tissueprostheses.Preclinicalworkhasconfirmedthatacceleratedlaparotomyrepairthrough
priming with tissue repair growth factors can significantly reduce the incisional hernia
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rate.4,6 The problem with single peptide wound therapy remains drug delivery, dosing, and
timing.
Histological samples of AMP-treated wounds are consistent with accelerated repair
over controls. There is more fibroplasia and angiogenesis. It is also suggested that the
intensityofthewoundinflammatoryresponseismodulatedandlesssevere.Collagenfibrils
appear more organized along natural lines of tension and the peritoneal lining appears
restored during AMP treatment.
A comprehensive examination of remote organs and tissue found no migration or
trafficking of AMP cells beyond the wound. This supports the application of AMP cells in
woundtherapy.Theimmuneprivilegeofamnion-derivedcellspermitsitsuseasanallograft
and the containment of these cells to the wound suggests its safety.
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